# US 2015/0104518 A1 · Enhanced nitric oxide delivery and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104518 A1
- Document ID: US20150104518A1
- Status: Published application
- Kind: A1
- Application number: 14/575,335
- Filed: 2014-12-18
- Published: 2015-04-16
- Earliest claimed: 2011-06-27
- Assignees: Albert Einstein College of Medicine of Yeshiva University
- Applicants: Albert Einstein College of Medicine of Yeshiva University
- Inventors: Adam Friedman; Joel Friedman; Joshua Nosanchuk; Parimala Nacharaju; Karin Blecher; Chaim Tuckman-Vernon
- Web page: https://patentgrep.com/patent/US20150104518A1

## CPC

- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 9/14: Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 9/5115: {Inorganic compounds}
- A61K 9/5123: {Organic compounds, e.g. fats, sugars}
- A61K 9/5146: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides}
- A61K 9/5161: {Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin}
- A61K 38/063: {Glutathione}
- A61K 47/20: containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Methods and compositions are disclosed that enhance delivery of nitric oxide (NO) by combining nitric oxide releasing nanoparticles (NO-np) with exogenous glutathione (GSH), as well as therapeutic uses of the methods and compositions.

## Claims

### Claim 1

A method for enhancing the efficacy of nitric oxide (NO) released from NO releasing nanoparticles (NO-np) comprising combining the NO-np with exogenous glutathione (GSH) so as to enhance the efficacy of NO that is released.

### Claim 2 (depends on 1)

The method of claim 1, wherein S-nitrosoglutathione (GSNO) is formed by reaction of NO with GSH.

### Claim 3 (depends on 1)

The method of claim 1, wherein GSH is dissolved in a carrier mixed with NO-np.

### Claim 4 (depends on 1)

The method of claim 1, wherein GSH is encapsulated in nanoparticles (GSM-np) and mixed with NO-np.

### Claim 5 (depends on 1)

A method of treating a microbial infection comprising applying NO to the microbes by combining NO-np and GSH according to the method of claim 1.

### Claim 6 (depends on 5)

The method of claim 5, wherein the infection is a bacterial, viral, fungal or parasitic infection.

### Claim 7 (depends on 6)

The method of claim 6, wherein the bacteria are methicillin resistant Staphylococcus aureus (MRSA), Escherichia coli, Kiebslella pneumoniae, Pseudomonas aeruginosa.

### Claim 8 (depends on 1)

A method of promoting wound healing or hair growth, or treating a burn in a subject comprising applying NO to the wound, hair or burn by combining NO-np and GSH according to the method of claim 1.

### Claim 9 (depends on 1)

A method of promoting angiogenesis or vasodilation in a subject comprising administering NO to the subject by combining NO-up and GSH according to the method of claim 1.

### Claim 10 (depends on 1)

A method of treating erectile dysfunction in a subject comprising topically applying NO to the penis of the subject by combining NO-np and GSH according to the method of claim 1.

### Claim 11 (depends on 1)

A method of administering nitric oxide (NO) to a subject comprising administering to the subject a combination of NO releasing nanoparticles (NO-np) and exogenous glutathione according to the method of claim 1.

### Claim 12 (depends on 11)

The method of claim 11, wherein the subject has a cardiovascular disorder, a pulmonary disorder, peripheral vascular disease, erectile dysfunction, scleroderma, sickle cell anemia, a microbial infection, a wound, a burn, an inflammatory skin disease, psoriasis or eczema.

### Claim 13

A composition for delivering nitric oxide (NO) comprising NO releasing nanoparticles (NO-np) and glutathione (GSH).

### Claim 14 (depends on 13)

The composition of claim 13, wherein S-nitrosoglutathione (GSNO) formed by reaction of NO with glutathione.

### Claim 15 (depends on 13)

The composition of claim 13, wherein GSH is dissolved in a carrier mixed with NO-np.

### Claim 16 (depends on 13)

The composition of claim 13, wherein GSH is encapsulated in nanoparticles (GSH-up) and mixed with NO-np.

### Claim 17 (depends on 13)

An antimicrobial agent, a wound healing accelerant, a pro-erectile agent, an anti-hypertensive agent, a pro-resuscitive agent, a blood storage stabilizer, an anti-vasospasmic agent, a chemotherapeutic agent, an immunomodulatory agent, or an anti-aging agent comprising the composition of claim 13.
